BioCentury | Apr 21, 2021
Management Tracks

EQRx adds Rubin, Rogers to C-suite; plus Allakos, Veracyte, Translate, Sutro and more

...of research and translational biology Laura Carter will succeed Salter-Cid as CSO. Stem cell transplant company Magenta Therapeutics Inc....
...partner at PE firm Asgard Partners. BC Staff EQRx Inc. Allakos Inc. Veracyte Inc. Translate Bio Inc. Sutro Biopharma Inc. Gossamer Bio Inc. Magenta Therapeutics Inc. Precision...
BioCentury | Nov 11, 2020
Management Tracks

Novavax brings in Tesaro’s Covino as it readies to market two vaccines; plus moves at Werewolf, Editas, Magenta, Pharming, Marinus and more

...joining the seizure disorder company, Shafer was business director of neurology at Alexion Pharmaceuticals Inc. (NASDAQ:ALXN).Magenta Therapeutics Inc....
...Johnson was SVP, head of regulatory and quality at Magenta. Danielle Golovin Novavax Inc. Editas Medicine Inc. Inozyme Pharma Inc. Magenta Therapeutics Inc. Pharming...
BioCentury | Sep 3, 2020
Management Tracks

Dier joining Ultragenyx as CFO; plus Magenta, Galectin, Immunicum, BrainStorm, Vaccinex

...until the former CFO and CBO of Portola Pharmaceuticals Inc. starts Nov. 2.Stem cell therapy play Magenta Therapeutics Inc....
BioCentury | Aug 6, 2020
Management Tracks

Kindler joins Blackstone as senior adviser; plus changes at Mission, Annexon, Dyne, Ribometrix, Autolus and more

...corporate strategy, finance and operations at Qpex Biopharma Inc.; Savage was senior medical director at Magenta Therapeutics Inc....
BioCentury | Jun 26, 2020
Finance

June 25 Quick Takes: Chi-Med rakes in $100M; plus bank rules rolled back, newco DeCART has June ties and more

...close. They include NantKwest Inc. (NASDAQ:NK) at $80.1 million; Castle Biosciences Inc. (NASDAQ:CSTL), $74 million; Magenta Therapeutics Inc....
...Casitas B cell lymphoma-b BioCentury Staff Nurix Therapeutics Inc. Hutchison China MediTech Ltd. Enterome Bioscience S.A. NantKwest Inc. Castle Biosciences Inc. Magenta Therapeutics Inc. Evelo...
BioCentury | Apr 18, 2020
Management Tracks

PTC names Matthew Klein as chief development officer; plus Cardurion, Sangamo, TCR2, Five Prime and more

...see "Ohana: Looking to the Other Half of Reproductive Biology" ). Stem cell therapy company Magenta Therapeutics Inc....
...Staff PTC Therapeutics Inc. uniQure N.V. Cardurion Pharmaceuticals LLC Sangamo Therapeutics Inc. TCR2 Therapeutics Inc. Five Prime Therapeutics Inc. Evelo Biosciences Inc. Ohana Biosciences Magenta Therapeutics Inc. Mesa...
BioCentury | Jan 7, 2020
Company News

Management tracks: Rhythm, Mirati, Aura, IFM, a16z, Cambrex, Alzheon and more

...SIX:NOVN). Immunotherapy company IFM Therapeutics LLC hired Michael Cooke as CSO. Cooke was CSO at Magenta Therapeutics Inc....
BioCentury | Oct 18, 2019
Company News

Management tracks: Sirtex makes interim CEO permanent; plus Magenta, Pyxis, Stoke, Cadent, StemoniX, Enzyvant, Syapse and Stalicla

...joining Sirtex, Smith was EVP of business development at Gel-e Inc. Stem cell therapy company Magenta Therapeutics Inc....
...a nonprofit with which Stalicla is collaborating. Jonathan Block, Associate Editor Enzyvant Sciences GmbH Stoke Therapeutics Inc. Sirtex Medical Ltd. Magenta Therapeutics Inc. Pyxis...
BioCentury | Jul 13, 2019
Finance

How crossover, insider support and big money correlated with performance across 1H19 IPOs

...Corp. (NASDAQ:TWST) 5/8/19 $90.6 $679.1 $938.1 38% Veracyte Inc. (NASDAQ:VCYT) 5/2/19 $147.1 $1,112.1 $1,363.8 23% Magenta Therapeutics Inc....
BioCentury | May 2, 2019
Financial News

May 2 Financial Quick Takes: Magenta, Clovis, Atomwise

...Magenta follow-on comes with haircut Stem cell transplant company Magenta Therapeutics Inc. (NASDAQ:MGTA) raised $56.3 million in a...
...specific target by the biotech’s AI platform, AtomNet (see “Testing Intelligence” ). BioCentury Staff Atomwise Inc. Clovis Oncology Inc. Magenta Therapeutics Inc. Y...
Items per page:
1 - 10 of 41
BioCentury | Apr 21, 2021
Management Tracks

EQRx adds Rubin, Rogers to C-suite; plus Allakos, Veracyte, Translate, Sutro and more

...of research and translational biology Laura Carter will succeed Salter-Cid as CSO. Stem cell transplant company Magenta Therapeutics Inc....
...partner at PE firm Asgard Partners. BC Staff EQRx Inc. Allakos Inc. Veracyte Inc. Translate Bio Inc. Sutro Biopharma Inc. Gossamer Bio Inc. Magenta Therapeutics Inc. Precision...
BioCentury | Nov 11, 2020
Management Tracks

Novavax brings in Tesaro’s Covino as it readies to market two vaccines; plus moves at Werewolf, Editas, Magenta, Pharming, Marinus and more

...joining the seizure disorder company, Shafer was business director of neurology at Alexion Pharmaceuticals Inc. (NASDAQ:ALXN).Magenta Therapeutics Inc....
...Johnson was SVP, head of regulatory and quality at Magenta. Danielle Golovin Novavax Inc. Editas Medicine Inc. Inozyme Pharma Inc. Magenta Therapeutics Inc. Pharming...
BioCentury | Sep 3, 2020
Management Tracks

Dier joining Ultragenyx as CFO; plus Magenta, Galectin, Immunicum, BrainStorm, Vaccinex

...until the former CFO and CBO of Portola Pharmaceuticals Inc. starts Nov. 2.Stem cell therapy play Magenta Therapeutics Inc....
BioCentury | Aug 6, 2020
Management Tracks

Kindler joins Blackstone as senior adviser; plus changes at Mission, Annexon, Dyne, Ribometrix, Autolus and more

...corporate strategy, finance and operations at Qpex Biopharma Inc.; Savage was senior medical director at Magenta Therapeutics Inc....
BioCentury | Jun 26, 2020
Finance

June 25 Quick Takes: Chi-Med rakes in $100M; plus bank rules rolled back, newco DeCART has June ties and more

...close. They include NantKwest Inc. (NASDAQ:NK) at $80.1 million; Castle Biosciences Inc. (NASDAQ:CSTL), $74 million; Magenta Therapeutics Inc....
...Casitas B cell lymphoma-b BioCentury Staff Nurix Therapeutics Inc. Hutchison China MediTech Ltd. Enterome Bioscience S.A. NantKwest Inc. Castle Biosciences Inc. Magenta Therapeutics Inc. Evelo...
BioCentury | Apr 18, 2020
Management Tracks

PTC names Matthew Klein as chief development officer; plus Cardurion, Sangamo, TCR2, Five Prime and more

...see "Ohana: Looking to the Other Half of Reproductive Biology" ). Stem cell therapy company Magenta Therapeutics Inc....
...Staff PTC Therapeutics Inc. uniQure N.V. Cardurion Pharmaceuticals LLC Sangamo Therapeutics Inc. TCR2 Therapeutics Inc. Five Prime Therapeutics Inc. Evelo Biosciences Inc. Ohana Biosciences Magenta Therapeutics Inc. Mesa...
BioCentury | Jan 7, 2020
Company News

Management tracks: Rhythm, Mirati, Aura, IFM, a16z, Cambrex, Alzheon and more

...SIX:NOVN). Immunotherapy company IFM Therapeutics LLC hired Michael Cooke as CSO. Cooke was CSO at Magenta Therapeutics Inc....
BioCentury | Oct 18, 2019
Company News

Management tracks: Sirtex makes interim CEO permanent; plus Magenta, Pyxis, Stoke, Cadent, StemoniX, Enzyvant, Syapse and Stalicla

...joining Sirtex, Smith was EVP of business development at Gel-e Inc. Stem cell therapy company Magenta Therapeutics Inc....
...a nonprofit with which Stalicla is collaborating. Jonathan Block, Associate Editor Enzyvant Sciences GmbH Stoke Therapeutics Inc. Sirtex Medical Ltd. Magenta Therapeutics Inc. Pyxis...
BioCentury | Jul 13, 2019
Finance

How crossover, insider support and big money correlated with performance across 1H19 IPOs

...Corp. (NASDAQ:TWST) 5/8/19 $90.6 $679.1 $938.1 38% Veracyte Inc. (NASDAQ:VCYT) 5/2/19 $147.1 $1,112.1 $1,363.8 23% Magenta Therapeutics Inc....
BioCentury | May 2, 2019
Financial News

May 2 Financial Quick Takes: Magenta, Clovis, Atomwise

...Magenta follow-on comes with haircut Stem cell transplant company Magenta Therapeutics Inc. (NASDAQ:MGTA) raised $56.3 million in a...
...specific target by the biotech’s AI platform, AtomNet (see “Testing Intelligence” ). BioCentury Staff Atomwise Inc. Clovis Oncology Inc. Magenta Therapeutics Inc. Y...
Items per page:
1 - 10 of 41